GC
KRRO icon

Guggenheim Capital’s Korro Bio KRRO Stock Holding History

Guggenheim Capital’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
18,400
+4,303
+31% +$53.5K ﹤0.01% 1586
2026
Q1 		$160K Buy
14,097
+3,658
+35% +$40.3K ﹤0.01% 1545
2025
Q4 		$83.6K Buy
+10,439
New +$244K ﹤0.01% 1727

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Guggenheim Capital's KRRO Position: Q2 2026 in Review

Guggenheim Capital increased its Korro Bio (KRRO) stake by 31% in Q2 2026, buying an estimated $53.5K and bringing the position to 18,400 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

Guggenheim Capital first reported a position in KRRO in Q4 2025 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Guggenheim Capital held 18,400 shares of Korro Bio worth $243K as of Q2 2026.
  • Guggenheim Capital bought 4,303 Korro Bio shares in Q2 2026, an estimated $53.5K.
  • Korro Bio made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1586 holding.
  • Guggenheim Capital first reported a position in Korro Bio in Q4 2025 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.